13 results
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
in type 2 diabetes ... - Algorithm # ... Diabetes #Medications ... #Algorithm #Pharmacology ... Hypoglycemic #Management #Endocrinology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications ... Meglitinides • GLP ... #Medications #pharmacology ... pathophysiology #endocrinology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... #Pharmacology #Dosing ... #Diabetes #DM2 ... #Endocrinology
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
weight of various classes ... of type-2 diabetes ... medications ... Weight Loss ++ - GLP ... weightgain #comparison #pharmacology
Hyperglycemia - Differential Diagnosis Algorithm
Diabetes Mellitus:
 • Impaired Glucose Tolerance
 • Type I Diabetes
 • Type
Differential Diagnosis Algorithm ... • Acromegaly Medications ... Differential #Diagnosis #Algorithm ... #endocrinology ... #causes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... not definitively cause ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... DPP-4 inhibitor, GLP ... #pharmacology # ... comparison #table #endocrinology
Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes

#Diabetes #Management #Algorithm #endocrinology #pharmacology #medications
Pharmacologic treatment ... #Diabetes #Management ... #Algorithm #endocrinology ... #pharmacology # ... medications
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... normally inactivates GLP ... not definitively cause ... #Summary #DM2 #diabetes ... #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Diabetes #Endocrinology